Cargando…

Cerebrospinal fluid and positron-emission tomography biomarkers for noradrenergic dysfunction in neurodegenerative diseases: a systematic review and meta-analysis

The noradrenergic system shows pathological modifications in aging and neurodegenerative diseases and undergoes substantial neuronal loss in Alzheimer’s disease and Parkinson’s disease. While a coherent picture of structural decline in post-mortem and in vivo MRI measures seems to emerge, whether th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lancini, Elisa, Haag, Lena, Bartl, Franziska, Rühling, Maren, Ashton, Nicholas J, Zetterberg, Henrik, Düzel, Emrah, Hämmerer, Dorothea, Betts, Matthew J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154713/ https://www.ncbi.nlm.nih.gov/pubmed/37151227 http://dx.doi.org/10.1093/braincomms/fcad085

Ejemplares similares

Noradrenergic-dependent functions are associated with age-related locus coeruleus signal intensity differences
por: Liu, Kathy Y., et al.
Publicado: (2020)

Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases
por: Betts, Matthew J, et al.
Publicado: (2019)

Commentary: Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice
por: Betts, Matthew J., et al.
Publicado: (2018)

Tau Imaging in Neurodegenerative Diseases Using Positron Emission Tomography
por: Wang, Yi Ting, et al.
Publicado: (2019)

Association of weight change with cerebrospinal fluid biomarkers and amyloid positron emission tomography in preclinical Alzheimer’s disease
por: Grau-Rivera, Oriol, et al.
Publicado: (2021)

Editorial: Blood Biomarkers of Neurodegenerative Diseases
por: Karikari, Thomas K., et al.
Publicado: (2022)

Older adults fail to form stable task representations during model-based reversal inference
por: Hämmerer, Dorothea, et al.
Publicado: (2019)

Cerebrospinal fluid microglia and neurodegenerative markers in twins concordant and discordant for psychotic disorders
por: Johansson, Viktoria, et al.
Publicado: (2016)

Noradrenergic Modulation of Fear Conditioning and Extinction
por: Giustino, Thomas F., et al.
Publicado: (2018)

Positron Emission Tomography (PET) and Neuroimaging in the Personalized Approach to Neurodegenerative Causes of Dementia
por: Ricci, Maria, et al.
Publicado: (2020)

(18)F-THK5351 Positron Emission Tomography Imaging in Neurodegenerative Tauopathies
por: Ezura, Michinori, et al.
Publicado: (2021)

Using florbetapir positron emission tomography to explore cerebrospinal fluid cut points and gray zones in small sample sizes
por: Weston, Philip S.J., et al.
Publicado: (2015)

Locus coeruleus integrity in old age is selectively related to memories linked with salient negative events
por: Hämmerer, Dorothea, et al.
Publicado: (2018)

Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission Tomography
por: Therriault, Joseph, et al.
Publicado: (2022)

Neurofilament light oligomers in neurodegenerative diseases: quantification by homogeneous immunoassay in cerebrospinal fluid
por: Meda, Francisco J., et al.
Publicado: (2023)

Longitudinal pathways of cerebrospinal fluid and positron emission tomography biomarkers of amyloid-β positivity
por: Sala, Arianna, et al.
Publicado: (2020)

In vivo visualization of age-related differences in the locus coeruleus
por: Liu, Kathy Y., et al.
Publicado: (2019)

Corrigendum to in vivo visualization of age-related differences in the locus coeruleus Neurobiology of Aging Volume 74, February 2019, Pages 101–111
por: Liu, Kathy Y., et al.
Publicado: (2020)

Age differences in diffusivity in the locus coeruleus and its ascending noradrenergic tract
por: Porat, Shai, et al.
Publicado: (2022)

Brain Molecular Connectivity in Neurodegenerative Diseases: Recent Advances and New Perspectives Using Positron Emission Tomography
por: Sala, Arianna, et al.
Publicado: (2019)

Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography
por: Palmqvist, Sebastian, et al.
Publicado: (2016)

Quantification of total apolipoprotein E and its isoforms in cerebrospinal fluid from patients with neurodegenerative diseases
por: Minta, K., et al.
Publicado: (2020)

Application of advanced brain positron emission tomography–based molecular imaging for a biological framework in neurodegenerative proteinopathies
por: Perani, Daniela, et al.
Publicado: (2019)

Positron emission tomography
Publicado: (1995)

Positron Emission Tomography
por: Piepmeier, Joseph M.
Publicado: (1986)

Positron emission tomography
por: Paans, A M J
Publicado: (2006)

β-Amyloid discordance of cerebrospinal fluid and positron emission tomography imaging shows distinct spatial tau patterns
por: Jiang, Chenyang, et al.
Publicado: (2022)

In vivo tractography of human locus coeruleus—relation to 7T resting state fMRI, psychological measures and single subject validity
por: Liebe, Thomas, et al.
Publicado: (2022)

The integrity of dopaminergic and noradrenergic brain regions is associated with different aspects of late-life memory performance
por: Dahl, Martin J., et al.
Publicado: (2023)

The Cerebrospinal Fluid in Multiple Sclerosis
por: Deisenhammer, Florian, et al.
Publicado: (2019)

The cerebrospinal fluid biomarker profile in an HIV-infected subject with Alzheimer’s disease
por: Mäkitalo, Signar, et al.
Publicado: (2015)

Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease
por: Nilsson, Johanna, et al.
Publicado: (2021)

Relevance of biomarkers across different neurodegenerative
por: Ehrenberg, Alexander J., et al.
Publicado: (2020)

Noradrenergic symptom cluster in depression
por: Montgomery, Stuart, et al.
Publicado: (2011)

Noradrenergic dysfunction in Alzheimer's disease
por: Gannon, Mary, et al.
Publicado: (2015)

The Noradrenergic System in Parkinson’s Disease
por: Paredes-Rodriguez, Elena, et al.
Publicado: (2020)

Shining light on the noradrenergic system
por: Tanguay, Emmeraude, et al.
Publicado: (2023)

Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases
por: Jesse, Sarah, et al.
Publicado: (2010)

YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias
por: Llorens, Franc, et al.
Publicado: (2017)

Metabolites and Biomarker Compounds of Neurodegenerative Diseases in Cerebrospinal Fluid
por: Wakamatsu, Keiji, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tgls0mqrap6pudt06ci0jncrh1